Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
Open accessThe DOI matches its Crossref record; 85 of the 86 references it cites were found in a registry or an index.
Abstract
Studies in animals have documented that, compared with glucose, dietary fructose induces dyslipidemia and insulin resistance. To assess the relative effects of these dietary sugars during sustained consumption in humans, overweight and obese subjects consumed glucose- or fructose-sweetened beverages providing 25% of energy requirements for 10 weeks. Although both groups exhibited similar weight gain during the intervention, visceral adipose volume was significantly increased only in subjects consuming fructose. Fasting plasma triglyceride concentrations increased by approximately 10% during 10 weeks of glucose consumption but not after fructose consumption. In contrast, hepatic de novo lipogenesis (DNL) and the 23-hour postprandial triglyceride AUC were increased specifically during fructose consumption. Similarly, markers of altered lipid metabolism and lipoprotein remodeling, including fasting apoB, LDL, small dense LDL, oxidized LDL, and postprandial concentrations of remnant-like particle-triglyceride and -cholesterol significantly increased during fructose but not glucose consumption. In addition, fasting plasma glucose and insulin levels increased and insulin sensitivity decreased in subjects consuming fructose but not in those consuming glucose. These data suggest that dietary fructose specifically increases DNL, promotes dyslipidemia, decreases insulin sensitivity, and increases visceral adiposity in overweight/obese adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Habitual consumption of significant amounts ( . 10% energy) of dietary fructose contributes to TG elevations, particularly in people with HTG.”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The impact of fructose/sucrose intake on HDL-C does not seem different from that of other refined carbohydrates.158,159”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Sucrose, a disaccharidecontaining glucose and fructose, represents an important source of fructose in the diet. 158,175”
From 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias (2016) · cites this paper as [158]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fructose has emerged as a potent activator of carbohydrate response element-binding protein (ChREBP), which is particularly relevant in the context of MASLD, given the global rise in fructose consumption that parallels the increasing prevalence of MASLD [78- 82].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [81]
Experimental — accuracy not yet measuredIn the citing paper
“dietary fructose contributes to TG elevations; these effects are dose dependent and become clinically relevant when the intake is .10%energy daily-with a habitual fructose consumption between 15 and 20% of the energy intake, plasma TG increases as much as 30 -40%.”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [76]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Follow-up report on the diagnosis of diabetes mellitus
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus* (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3160 · Cited by 3,784
A new predictive equation for resting energy expenditure in healthy individuals
Mifflin, M., St Jeor, S., Hill, L., Scott, B., Daugherty, S., & Koh, Y. (1990) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/51.2.241 · Cited by 2,544 · cited 1×
“calculated by the Mifflin equation (67), with an adjustment of 1.”
MethodNordestgaard, B. G., Benn, M., Schnohr, P., & Tybjærg-Hansen, A. (2007) · JAMA · doi:10.1001/jama.298.3.299 · Cited by 2,058
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561 · cited 1×
“Diacylglycerol is a known activator of novel PKC (51), and increases of both diacylglycerol and novel PKC activity are associated with lipid-induced insulin resistance (52, 53).”
BackgroundItani, S. I., Ruderman, N. B., Schmieder, F., & Boden, G. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2005 · Cited by 1,390
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Metabolic origins and clinical significance of LDL heterogeneity
Berneis, K. K., & Krauss, R. M. (2002) · Journal of Lipid Research · doi:10.1194/jlr.r200004-jlr200 · Cited by 896
Self-citationMorino, K., Petersen, K. F., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-s002 · Cited by 853 · cited 1×
“We propose that the increased hepatic lipid resulting from fructose-induced DNL leads to hepatic insulin resistance (49, 50), possibly by increasing levels of diacylglycerol (49).”
BackgroundConway, J. M., Ingwersen, L. A., Vinyard, B. T., & Moshfegh, A. J. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1171 · Cited by 820
Research works printed but not linked: 1
- Schwarz, J.M., Neese, R.A., Schakleton, C., and Hellerstein, M.K. 1993. De novo lipogenesis during fasting and oral fructose ingestion in lean and obese hyperinsulinemic subjects [abstract]. Diabetes. 42 :A39.
Cited by
Items 201–300 of 1,008
Uric Acid Promotes Left Ventricular Diastolic Dysfunction in Mice Fed a Western Diet
Jia, G., Habibi, J., Bostick, B. P., Ma, L., DeMarco, V. G., Aroor, A. R., Hayden, M. R., Whaley-Connell, A. T., & Sowers, J. R. (2015) · Hypertension · doi:10.1161/hypertensionaha.114.04737 · Cited by 140
Novel Insights in the Metabolic Syndrome in Childhood and Adolescence
Bussler, S., Penke, M., Flemming, G. M. C., Elhassan, Y., Kratzsch, J., Sergeyev, E., Lipek, T., Vogel, M., Spielau, U., Körner, A., et al. (2017) · Hormone Research in Paediatrics · doi:10.1159/000479510 · Cited by 156
Caton, P. W., Kieswich, J., Yaqoob, M. M., Holness, M. J., & Sugden, M. C. (2011) · Diabetologia · doi:10.1007/s00125-011-2288-0 · Cited by 140
“In humans, elevated intake of sugar-sweetened beverages is associated with an increased risk of the metabolic syndrome and type 2 diabetes [21, 22], whilst fructose consumption has been reported to worsen metabolic abnormalities in obese humans to a greater extent than glucose consumption [23, 24].”
BackgroundChiavaroli, L., de Souza, R. J., Ha, V., Cozma, A. I., Mirrahimi, A., Wang, D. D., Yu, M., Carleton, A. J., Di Buono, M., Jenkins, A. L., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001700 · Cited by 137
Today's and yesterday's of pathophysiology: Biochemistry of metabolic syndrome and animal models
Aydın, S., Aksoy, A., Aydın, S., Kalaycı, M. Z., Yılmaz, M., Kuloğlu, T., Çitil, C., & Çatak, Z. (2013) · Nutrition · doi:10.1016/j.nut.2013.05.013 · Cited by 148
Challenging the Fructose Hypothesis: New Perspectives on Fructose Consumption and Metabolism
White, J. S. (2013) · Advances in Nutrition · doi:10.3945/an.112.003137 · Cited by 152
The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
Moore, J., Gunn, P., & Fielding, B. (2014) · Nutrients · doi:10.3390/nu6125679 · Cited by 133
Corte, K. W. D., Perrar, I., Penczynski, K. J., Schwingshackl, L., Herder, C., & Buyken, A. E. (2018) · Nutrients · doi:10.3390/nu10050606 · Cited by 149
Wölnerhanssen, B. K., Cajacob, L., Keller, N., Doody, A., Rehfeld, J. F., Drewe, J., Peterli, R., Beglinger, C., & Meyer‐Gerspach, A. C. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00037.2016 · Cited by 146
Sahin, A. W., Zannini, E., Coffey, A., & Arendt, E. K. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108583 · Cited by 125
Kirkpatrick, C. F., Sikand, G., Petersen, K. S., Anderson, C. A. M., Aspry, K. E., Bolick, J. P., Kris-Etherton, P. M., & Maki, K. C. (2023) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2023.05.099 · Cited by 118
Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health
Melo, H. M., Santos, L. E., & Ferreira, S. T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00265 · Cited by 136
The Impact of Free Sugar on Human Health—A Narrative Review
Gillespie, K. M., Kemps, E., White, M. J., & Bartlett, S. E. (2023) · Nutrients · doi:10.3390/nu15040889 · Cited by 162
Bettaieb, A., Prieto, M. A. V., Lanzi, C. R., Miatello, R. M., Haj, F. G., Fraga, C. G., & Oteiza, P. I. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.011 · Cited by 140
Blevins, J. E., & Baskin, D. G. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.05.023 · Cited by 134
DiNicolantonio, J. J., Mehta, V., Onkaramurthy, N. J., & O’Keefe, J. H. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.12.001 · Cited by 148
Tanaka, Y., Shimanaka, Y., Caddeo, A., Kubo, T., Mao, Y., Kubota, T., Kubota, N., Yamauchi, T., Mancina, R. M., Baselli, G., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-320646 · Cited by 132
Soft drink consumption and obesity: it is all about fructose
Bray, G. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283346ca2 · Cited by 132
Tolerable upper intake level for dietary sugars
EFSA Panel on Nutrition, N. F. A. F. A. (., Turck, D., Bohn, T., Castenmiller, J. J. M., Henauw, S. D., Hirsch‐Ernst, K. I., Knutsen, H. K., Maciuk, A., Mangelsdorf, I., McArdle, H. J., et al. (2022) · EFSA Journal · doi:10.2903/j.efsa.2022.7074 · Cited by 169
Cox, C. L., Stanhope, K. L., Schwarz, J. M., Graham, J. L., Hatcher, B., Griffen, S. C., Bremer, A. A., Berglund, L., McGahan, J. P., Havel, P. J., et al. (2012) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.159 · Cited by 132
Self-citationTherapeutic potential of green tea in nonalcoholic fatty liver disease
Masterjohn, C., & Bruno, R. S. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00440.x · Cited by 130
Gut-liver interaction in triglyceride-rich lipoprotein metabolism
Xiao, C., Hsieh, J., Adeli, K., & Lewis, G. F. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00178.2011 · Cited by 127
Jenkins, D. J. A., Srichaikul, K., Kendall, C. W. C., Sievenpiper, J. L., Abdulnour, S., Mirrahimi, A., Meneses, C., Nishi, S., He, X., Lee, S., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1927-1 · Cited by 130
Liver Fat in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Yki-Järvinen, H. (2010) · Digestive Diseases · doi:10.1159/000282087 · Cited by 126
Sanchez-Villegas, A., Zazpe, I., Santiago, S., Perez-Cornago, A., Martinez-Gonzalez, M. A., & Lahortiga-Ramos, F. (2018) · British Journal of Nutrition · doi:10.1017/s0007114517003361 · Cited by 118
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges
Goldner, D. L., & Lavine, J. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.01.048 · Cited by 149
Madero, M., Arriaga, J. C., Jalal, D. I., Rivard, C. J., McFann, K., Pérez-Méndez, O. A., Vázquez, A., Ruiz, A., Lanaspa, M. A., Jimenez, C. A. R., et al. (2011) · Metabolism · doi:10.1016/j.metabol.2011.04.001 · Cited by 140
Fructose-containing caloric sweeteners as a cause of obesity and metabolic disorders
Tappy, L. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.164202 · Cited by 126
Dulloo, A. G. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00909.x · Cited by 118
ter Horst, K. W., Schene, M. R., Holman, R., Romijn, J. A., & Serlie, M. J. M. (2016) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.137786 · Cited by 134
Stanhope, K. L., & Havel, P. J. (2009) · Journal of Nutrition · doi:10.3945/jn.109.106641 · Cited by 144
Self-citationLuo, S., Monterosso, J. R., Sarpelleh, K., & Page, K. A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503358112 · Cited by 118
Jacome-Sosa, M. M., & Parks, E. J. (2014) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000080 · Cited by 118
Potential Health Risks From Beverages Containing Fructose Found in Sugar or High-Fructose Corn Syrup
Bray, G. A. (2013) · Diabetes Care · doi:10.2337/dc12-1631 · Cited by 123
Taskinen, M. ‐., Söderlund, S., Bogl, L. H., Hakkarainen, A., Matikainen, N., Pietiläinen, K. H., Räsänen, S., Lundbom, N., Björnson, E., Eliasson, B., et al. (2017) · Journal of Internal Medicine · doi:10.1111/joim.12632 · Cited by 117
Jin, R., Welsh, J., Le, N.-A., Holzberg, J., Sharma, P., Martin, D., & Vos, M. (2014) · Nutrients · doi:10.3390/nu6083187 · Cited by 118
Carbotoxicity—Noxious Effects of Carbohydrates
Kroemer, G., López-Otín, C., Madeo, F., & de Cabo, R. (2018) · Cell · doi:10.1016/j.cell.2018.07.044 · Cited by 117
Andrés-Hernando, A., Orlicky, D. J., Kuwabara, M., Ishimoto, T., Nakagawa, T., Johnson, R. J., & Lanaspa, M. A. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.05.012 · Cited by 126
How Inflammation Impinges on NAFLD: A Role for Kupffer Cells
Duarte, N., Coelho, I. C., Patarrão, R. S., Almeida, J. I., Penha-Gonçalves, C., & Macedo, M. P. (2015) · BioMed Research International · doi:10.1155/2015/984578 · Cited by 120
“A recent study suggested that fructose consumption may specifically promote lipid deposition in visceral adipose tissue, particularly in men, whereas glucose consumption appears to favor subcutaneous adiposity [36].”
Pollock, N. K., Bundy, V. L., Kanto, W. P., Davis, C. L., Bernard, P. J., Zhu, H., Gutin, B., & Dong, Y. (2011) · Journal of Nutrition · doi:10.3945/jn.111.150219 · Cited by 133
Visceral Adipose Tissue: The Hidden Culprit for Type 2 Diabetes
Dhokte, S., & Czaja, K. (2024) · Nutrients · doi:10.3390/nu16071015 · Cited by 134
Crescenzo, R., Bianco, F., Falcone, I., Coppola, P., Liverini, G., & Iossa, S. (2012) · European Journal of Nutrition · doi:10.1007/s00394-012-0356-y · Cited by 127
Does fructose consumption contribute to non-alcoholic fatty liver disease?
Tappy, L., & Lê, K. (2012) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2012.06.005 · Cited by 127
Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues
Baena, M., Sangüesa, G., Dávalos, A., Latasa, M.-J., Sala‐Vila, A., Sánchez, R. M., Roglans, N., Laguna, J. C., & Alegret, M. (2016) · Scientific Reports · doi:10.1038/srep26149 · Cited by 118
Wu, J. H. Y., Lemaître, R. N., Imamura, F., King, I. B., Song, X., Spiegelman, D. L., Siscovick, D. S., & Mozaffarian, D. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.012054 · Cited by 128
Vreman, R. A., Goodell, A. J., Rodríguez, L. A., Porco, T. C., Lustig, R. H., & Kahn, J. G. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013543 · Cited by 123
Camilleri, M., Lyle, B. J., Madsen, K. L., Sonnenburg, J. L., Verbeke, K., & Wu, G. D. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00063.2019 · Cited by 125
Sugar-Sweetened Beverage Taxes in Brazil
Claro, R. M., Levy, R. B., Popkin, B. M., & Monteiro, C. A. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300313 · Cited by 112
The Dose Makes the Poison: Sugar and Obesity in the United States – a Review
Faruque, S., Tong, J., Lacmanovic, V., Agbonghae, C., Minaya, D. M., & Czaja, K. (2019) · Polish Journal of Food and Nutrition Sciences · doi:10.31883/pjfns/110735 · Cited by 126
DiNicolantonio, J. J., & Lucan, S. C. (2014) · Open Heart · doi:10.1136/openhrt-2014-000167 · Cited by 126
Drożdż, K., Nabrdalik, K., Hajzler, W., Kwiendacz, H., Gumprecht, J., & Lip, G. Y. H. (2021) · Nutrients · doi:10.3390/nu14010103 · Cited by 122
Added sugars and periodontal disease in young adults: An analysis of NHANES III data
Lula, E. C., Ribeiro, C. C., Hugo, F. N., Alves, C. M., & Silva, A. A. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.089656 · Cited by 112
Pereira, C., Azevedo, I., Monteiro, R., & Martins, M. J. (2012) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01582.x · Cited by 126
Trumbo, P. R., & Rivers, C. R. (2014) · Nutrition Reviews · doi:10.1111/nure.12128 · Cited by 105
Munshi, R., Joshi, S., & Rane, B. (2014) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.132156 · Cited by 136
Macronutrients and the Adipose-Liver Axis in Obesity and Fatty Liver
Duwaerts, C. C., & Maher, J. J. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2019.02.001 · Cited by 123
Comparison of free fructose and glucose to sucrose in the ability to cause fatty liver
Sánchez-Lozada, L. G., Mu, W., Roncal, C., Sautin, Y. Y., Abdelmalek, M., Reungjui, S., Le, M., Nakagawa, T., Lan, H. Y., Yu, X., et al. (2010) · European Journal of Nutrition · doi:10.1007/s00394-009-0042-x · Cited by 105
Aune, D., Chan, D. S. M., Vieira, A. R., Navarro Rosenblatt, D. A., Vieira, R., Greenwood, D. C., Cade, J. E., Burley, V. J., & Norat, T. (2012) · Annals of Oncology · doi:10.1093/annonc/mds076 · Cited by 111
Catechin and quercetin attenuate adipose inflammation in fructose‐fed rats and 3T3‐L1 adipocytes
Vazquez Prieto, M. A., Bettaieb, A., Rodriguez Lanzi, C., Soto, V. C., Perdicaro, D. J., Galmarini, C. R., Haj, F. G., Miatello, R. M., & Oteiza, P. I. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400631 · Cited by 107
Koo, H.-Y., Miyashita, M., Cho, B. H. S., & Nakamura, M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.109 · Cited by 121
Health Implications of High-Fructose Intake and Current Research
Dornas, W., de Lima, W. G., Pedrosa, M. L., & Silva, M. E. (2015) · Advances in Nutrition · doi:10.3945/an.114.008144 · Cited by 126
Al‐Jawaldeh, A., Taktouk, M., & Nasreddine, L. (2020) · Nutrients · doi:10.3390/nu12113345 · Cited by 124
Roeb, E., Canbay, A. E., Tacke, F., Bantel, H., Bojunga, J., de Laffolie, J., Demir, M., Denzer, U. W., Geier, A., Hofmann, W. P., et al. (2022) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1880-2283 · Cited by 125
Harrell, C. S., Burgado, J., Kelly, S. D., Johnson, Z. P., & Neigh, G. N. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.08.025 · Cited by 107
Saad, A. F., Dickerson, J., Kechichian, T. B., Yin, H., Gamble, P., Salazar, A. E., Patrikeev, I., Motamedi, M., Saade, G. R., & Costantine, M. M. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.038 · Cited by 113
Beisner, J., Gonzalez‐Granda, A., Basrai, M., Damms-Machado, A., & Bischoff, S. C. (2020) · Nutrients · doi:10.3390/nu12113444 · Cited by 113
Betaine supplementation protects against high-fructose-induced renal injury in rats
Fan, C., Wang, M., Ge, C., Wang, X., Li, J., & Kong, L. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.010 · Cited by 108
Dietary fructose induces endotoxemia and hepatic injury in calorically controlled primates
Kavanagh, K., Wylie, A. T., Tucker, K. L., Hamp, T. J., Gharaibeh, R. Z., Fodor, A. A., & Cullen, J. M. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.057331 · Cited by 116
Hydes, T., Alam, U., & Cuthbertson, D. J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.640557 · Cited by 117
Nonfluoride caries-preventive agents
Rethman, M. P., Beltrán‐Aguilar, E. D., Billings, R. J., Burne, R. A., Clark, M. B., Donly, K. J., Hujoel, P. P., Katz, B. P., Milgrom, P., Sohn, W., et al. (2011) · The Journal of the American Dental Association · doi:10.14219/jada.archive.2011.0329 · Cited by 128
Increased Fructose Intake as a Risk Factor For Dementia
Stephan, B. C. M., Wells, J. C. K., Brayne, C., Albanese, E., & Siervo, M. (2010) · The Journals of Gerontology Series A · doi:10.1093/gerona/glq079 · Cited by 107
Are Liquid Sugars Different from Solid Sugar in Their Ability to Cause Metabolic Syndrome?
Sundborn, G., Thornley, S., Merriman, T. R., Lang, B., King, C., Lanaspa, M. A., & Johnson, R. J. (2019) · Obesity · doi:10.1002/oby.22472 · Cited by 103
Franz, M., Boucher, J. L., & Evert, A. B. (2014) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s45140 · Cited by 97
Tsuchiya, H., Ebata, Y., Sakabe, T., Hama, S., Kogure, K., & Shiota, G. (2012) · Metabolism · doi:10.1016/j.metabol.2012.06.008 · Cited by 108
Nutrition, the visceral immune system, and the evolutionary origins of pathogenic obesity
West-Eberhard, M. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1809046116 · Cited by 98
Exercise Prevents Fructose-Induced Hypertriglyceridemia in Healthy Young Subjects
Egli, L., Lecoultre, V., Theytaz, F., Campos, V., Hodson, L., Schneiter, P., Mittendorfer, B., Patterson, B. W., Fielding, B. A., Gerber, P. A., et al. (2013) · Diabetes · doi:10.2337/db12-1651 · Cited by 102
“Some of these effects may be related, at least in part, to the fact that fructose can be converted into fatty acids, which has been demonstrated after both acute (23) and chronic (18) fructose feeding.”
BackgroundThe role of ChREBP in carbohydrate sensing and NAFLD development
Régnier, M., Carbinatti, T., Parlati, L., Benhamed, F., & Postic, C. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00809-4 · Cited by 101
Diet, lipids, and cardiovascular disease
Siri‐Tarino, P. W., & Krauss, R. M. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000310 · Cited by 112
Self-citationOttum, M. S., & Mistry, A. M. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-3 · Cited by 98
Regulation of SERCA pumps expression in diabetes
Zarain‐Herzberg, Á., García‐Rivas, G., & Estrada‐Avilés, R. (2014) · Cell Calcium · doi:10.1016/j.ceca.2014.09.005 · Cited by 107
Dafny-Yelin, M., Glazer, I., Bar‐Ilan, I., Kerem, Z., Holland, D., & Amir, R. (2010) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf904337t · Cited by 103
Intestinal, but not hepatic, ChREBP is required for fructose tolerance
Kim, M., Astapova, I. I., Flier, S. N., Hannou, S. A., Doridot, L., Sargsyan, A., Kou, H. H., Fowler, A. J., Liang, G., & Herman, M. A. (2017) · JCI Insight · doi:10.1172/jci.insight.96703 · Cited by 93
Andrés-Hernando, A., Cicerchi, C., Kuwabara, M., Orlicky, D. J., Sánchez‐Lozada, L. G., Nakagawa, T., Johnson, R. J., & Lanaspa, M. A. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00454-z · Cited by 99
Fructose Might Contribute to the Hypoglycemic Effect of Honey
Erejuwa, O. O., Sulaiman, S. A., & Wahab, M. S. A. (2012) · Molecules · doi:10.3390/molecules17021900 · Cited by 104
Are Fruit Juices Healthier Than Sugar-Sweetened Beverages? A Review
Pepin, A., Stanhope, K. L., & Imbeault, P. (2019) · Nutrients · doi:10.3390/nu11051006 · Cited by 105
Self-citationPharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction
Gutierrez, J. A., Liu, W., Perez, S., Xing, G., Sonnenberg, G., Kou, K., Blatnik, M., Allen, R., Weng, Y., Vera, N. B., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101196 · Cited by 93
Adropin: An endocrine link between the biological clock and cholesterol homeostasis
Ghoshal, S., Stevens, J. R., Billon, C., Clemence, G., Sitaula, S., Leon, A. S., Rao, D. C., Skinner, J. S., Rankinen, T., Bouchard, C., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.12.002 · Cited by 104
Self-citationTaee, F. A., Zerafati-Shoae, N., Dehghani, M., Sadeghi, M., Baradaran, H. R., & Jazayeri, S. (2018) · European Journal of Nutrition · doi:10.1007/s00394-018-1711-4 · Cited by 104
Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat
Sheludiakova, A., Rooney, K. B., & Boakes, R. A. (2011) · European Journal of Nutrition · doi:10.1007/s00394-011-0228-x · Cited by 104
Dietary Sugar and Body Weight: Have We Reached a Crisis in the Epidemic of Obesity and Diabetes?
Kahn, R., & Sievenpiper, J. L. (2014) · Diabetes Care · doi:10.2337/dc13-2506 · Cited by 90
Rare mono- and disaccharides as healthy alternative for traditional sugars and sweeteners?
van Laar, A., Grootaert, C., & Camp, J. V. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1743966 · Cited by 103
Fructose and Risk of Cardiometabolic Disease
Bray, G. A. (2012) · Current Atherosclerosis Reports · doi:10.1007/s11883-012-0276-6 · Cited by 93
Li, J., Ge, C., Xu, M., Wang, W., Yu, R., Fan, C., & Kong, L. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400307 · Cited by 90
Fructose metabolism, cardiometabolic risk, and the epidemic of coronary artery disease
Mirtschink, P., Jang, C., Arany, Z. P., & Krek, W. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx518 · Cited by 105
Yang, W., Jiang, W., & Guo, S. (2023) · Nutrients · doi:10.3390/nu15214671 · Cited by 115
Zhang, Q., Pan, Y., Wang, R., Kang, L.-L., Xue, Q., Wang, X., & Kong, L. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.11.014 · Cited by 97
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
Kang, G. G., Trevaskis, N. L., Murphy, A. J., & Febbraio, M. A. (2023) · iScience · doi:10.1016/j.isci.2022.105905 · Cited by 94
“In well-controlled human studies, a fructose-rich diet does not increase body weight when compared with a diet matched for energy from glucose.(26) Nevertheless, fructose elicits more deleterious liver pathology than glucose; highlighting the complex interplay between diet and obesity-induced NAFLD/NASH.”
BackgroundMurine CD103+ dendritic cells protect against steatosis progression towards steatohepatitis
Heier, E.-C., Meier, A., Julich-Haertel, H., Djudjaj, S., Rau, M., Tschernig, T., Geier, A., Boor, P., Lammert, F., & Lukacs-Kornek, V. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.01.008 · Cited by 94
Ma, J., McKeown, N. M., Hwang, S.-J., Hoffmann, U., Jacques, P. F., & Fox, C. S. (2016) · Circulation · doi:10.1161/circulationaha.115.018704 · Cited by 84
Hernandez, E. D., Zheng, L., Kim, Y., Fang, B., Liu, B., Valdez, R., Dietrich, W. F., Rucker, P. V., CHIANELLI, D., Schmeits, J., et al. (2019) · Hepatology Communications · doi:10.1002/hep4.1368 · Cited by 98
Metadata
- Authors
- Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., McGahan, J. P., Seibert, A., Krauss, R. M., Chiu, S., Schaefer, E. J., Ai, M., Otokozawa, S., Nakajima, K., Nakano, T., Beysen, C., Hellerstein, M. K., Berglund, L., & Havel, P. J.
- Affiliations
- University of California, Davis (US)
- University of California, San Francisco (US)
- United States Department of Agriculture (US)
- Touro University California (US)
- UCSF Benioff Children's Hospital (US)
- Tufts University (US)
- KineMed (United States) (US)
- VA Northern California Health Care System (US)
- Corresponding author
- Havel, Peter J.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2009-05-01
- Volume
- 119
- Issue
- 5
- Pages
- 1322-1334
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC2673878
- OpenAlex
- W2146966453
- Cited by
- 1,765
- References
- 86
- Citations by year
- 2026: 56 · 2025: 73 · 2024: 56 · 2023: 96 · 2022: 92 · 2021: 101 · 2020: 113 · 2019: 112 · 2018: 135 · 2017: 105 · 2016: 118 · 2015: 121 · 2014: 135 · 2013: 143 · 2012: 108
- FWCI
- 74.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- American Diabetes Association (UL1 RR024146)
- U.S. Department of Agriculture (5306‐51530‐016‐00D, UL1 RR024146)
- Bristol-Myers Squibb
- Pfizer
- Sanofi
- American College of Radiology Imaging Network
- School of Veterinary Medicine, University of California, Davis
- KineMed
- Novo Nordisk
- Otsuka Pharmaceutical
- National Institutes of Health (AT‐003545, 5r01hl075675-05, 5r01hl091333-02, HL‐091333, R01 HL-075675, HL‐075675, RR024146)
- University of California, Davis (95616, RR024146, UL1 RR024146)
- Agricultural Research Service (5306‐51530‐016‐00D)
- National Heart, Lung, and Blood Institute (R01 HL-075675, R01 HL-091333, HL-091333, R01HL107256)
- National Center for Research Resources (RR-024146, 5306-51530-016-00D, UL1RR024146)
- National Center for Complementary and Integrative Health (AT0-02993, AT0-03545, AT 002599, R21AT002993, R21AT002599)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- dietary fructose, glucose, visceral fat, insulin resistance, insulin sensitivity, dyslipidemia, hepatic de novo lipogenesis, triglycerides, lipoprotein remodeling, oxidized LDL, remnant-like particles, overweight and obesity, weight gain
- MeSH terms
- Beverages, Blood Glucose, Body Weight, Energy Intake, Double-Blind Method, Eating, Female, Fructose, Glucose, Humans, Insulin, Insulin Resistance, Lipids, Lipoproteins, Liver, Male, Middle Aged, Models, Biological, Obesity, Sex Characteristics, Triglycerides, Gene Expression, Dietary Sucrose, Subcutaneous Fat, Intra-Abdominal Fat, Overweight, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.